CLINIPATH MALAYSIA SDN BHD (248187-W) Req No : 101443258

No.23, Galeri Empire NURUL DIANA BINTI ZAKARIA

Jalan Empayar Off Persiaran
DR MOGAN
Sultan Ibrahim/KU1 MEDIKLINIK MIKHAIL
41150 Klang Bandar Diraja
Selangor Darul Ehsan
7-1 JALAN DATARAN SURIA,
Tel: (03) 3342 2828 (H.Line) 15/7/1 DATARAN SURIA,
Fax: (03) 3343 5858 PUNCAK ALAM, SELANGOR 42300
Email: clinipath@tm.net.my Sex : Female Age : 36 PHONE : 03-3393 0528
Website: www.clinipath.com.my I/C : 850312015254
Service Date: 25/05/2021
RESULTS: TEL 3342 2828

Date of Sample Collection: 25/05/2021

SARS-CORONAVIRUS-2 PCR ASSAY (Novel Coronavirus / COVID-19)

Nature of Specimen: Nasopharyngeal / Oropharyngeal Swab

Method: Real time reverse transcription PCR

Screening Assay for SARS-CoV-2: Not Detected

Important Information on RT-PCR Test

Multiplex Real Time Reverse Transcriptase PCR (RT-PCR) which simultaneously detects several
Coronavirus specific genes such as E, N, S, RdRp, ORF1ab.
This RT-PCR assay is specific and sensitive having a limit of detection ranging from 3.8 copys /
reaction (RdRp), 10 copys / reaction (ORF1ab, N, S) and 5.2 copys / reaction for E gene.

A "Detected" result strongly indicates infection and should be read in conjunction with clinical symptoms,
exposure, travel and epidemiological history.

A "Not Detected" result may necessitate repeat sampling if there is a strong suspicion of Covid-19 disease.

This RT PCR assay is only a qualitative assay; Quantitation assay is not commercially available yet to give exact
viral load or exact ct value, (or cut off value) that can differentiate transmissible infective virus from non infective
virus. In addition the ct value in sample depends also on various other factors such as method of sampling
maintenance of cold storage transport and storage, the type/brand of reagents used, the PCR platform in use,
the viral genes targeted in assay, etc.
Any interpretations made by person requesting RT-PCR test is at his/her own discretion with regards to virus
infectivity, virus transmissiblity, quantity of Viral RNA etc. in sample

It is also recommended to test for other respiratory viruses in the Respiratory Panel 33 PCR in severely
ill patients to exclude or confirm the role of other co-infecting pathogens.

Ref: Guidelines COVID-19 Management in Malaysia No: 05/2020 (Edisi Kelima) Dated 25 March 2020

Note: Please refer to Clinipath website for the test methods Final Report
Test(s) Requested : . NCOV2
Service Date : 25/05/2021 Report Date : 25/05/2021 Report Time: 22:56 Validated by : SUBAASHINI THANAPALAN Page 1 of 1